Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03YWY
|
|||
| Drug Name |
PMID27215781-Compound-30
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H26F2N2O
|
|||
| Canonical SMILES |
COC1=NC=C(C2=C1C3CCC2C3)NC45CC6CC(C4)(CC(C6)(C5)F)F
|
|||
| InChI |
1S/C21H26F2N2O/c1-26-18-17-14-3-2-13(4-14)16(17)15(8-24-18)25-21-7-12-5-19(22,10-21)9-20(23,6-12)11-21/h8,12-14,25H,2-7,9-11H2,1H3
|
|||
| InChIKey |
YKIONNFZUQIKPS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.